Kobayashi Pharmaceutical (4967.T) traded down -0.99 % during a 24 hours period ending at 10:41 AM Central Europe on Wednesday 28th. One Kobayashi Pharmaceutical stock can currently be bought for about JPY 6,978 on popular exchanges. Current supply of Kobayashi Pharmaceutical stocks is 75.1 mn. Kobayashi Pharmaceutical has a current market capitalization of JPY 533 bn and approximately JPY 1 bn worth of Kobayashi Pharmaceutical was traded on exchanges in the last 24 hours. Since last month end, Kobayashi Pharmaceutical has traded 2.59 % up. Simple moving average of last 200 days is at JPY 5,813.81. The highest price of past 52 weeks was recorded at JPY 7,388 on 10/16/2026. 52 weeks low was at JPY 5,030 on 10/30/2025.
Here is how related stocks have performed in the past 24 hours:
Nof (4403.T) traded up 0.78 % and now trades at JPY 2,788. Current market capitalisation for Nof is JPY 626.3 bn. Nof has a current price to earnings ratio of 16.39.
Hirogin (7337.T) traded up 1.87 % and now trades at JPY 2,169.5. Hirogin has a market capitalisation of JPY 625.5 bn. Hirogin has a current price to earnings ratio of 13.92.
Kewpie (2809.T) traded down -1.04 % and now trades at JPY 4,450. Kewpie has a market capitalisation of JPY 622.2 bn. Current price/earnings ratio for Kewpie is 24.22.
Kyushu (7180.T) traded up 2.82 % and now trades at JPY 1,511.5. Kyushu has a market capitalisation of JPY 622.6 bn. Kyushu has a current price to earnings ratio of 17.45.
Rohto Pharmaceutical (4527.T) traded down -1.71 % and now trades at JPY 2,696.5. Current market capitalisation for Rohto Pharmaceutical is JPY 627.6 bn. Rohto Pharmaceutical has a current price to earnings ratio of 19.43.
About Kobayashi Pharmaceutical
Kobayashi Pharmaceutical Co., Ltd. is a company based in Osaka, Japan, which specializes in the manufacturing and wholesaling of pharmaceuticals and medical equipment. Additionally, they develop and manufacture fragrances, deodorant, sanitary products, and ointment for stiff shoulders, and export these to Southeast Asia and the US.
